A single centre longitudinal retrospective study in France in 102 poorly controlled T2D patients (HbA1c 9.3 %) showed a −1.5 % HbA1c drop after the switch from a MDI regimen to CSII with no change in insulin requirement. This evidence concerns the gene INS and type 2 diabetes mellitus.